Guerrillas threaten Colombia’s local elections
Colombia’s ceasefire talks with ELN rebels extended
NGO’s urge Colombia to sink investor protection treaties
Bogota court refuses to drop fraud and bribery...
Petro ends ceasefire with FARC dissidents in south...
Colombia’s prosecution cornered over drug links
Paramilitaries threaten to kill judges of Colombia’s war...
Colombia’s government and ELN rebels begin ceasefire talks
Petro seeks to govern Colombia without majority in...
Petro dissolves Colombia’s government coalition
  • About
  • Support
  • Newsletter
  • Contact
Colombia News | Colombia Reports
  • News
    • General
    • Analysis
    • War and peace
    • Elections
    • Economy
    • Culture
    • Sports
    • Science and Tech
  • Travel
    • General
    • Bogota
    • Medellin
    • Cali
    • Cartagena
    • Antioquia
    • Caribbean
    • Pacific
    • Coffee region
    • Amazon
    • Southwest Colombia
    • Northeast Colombia
    • Central Colombia
  • Data
    • Economy
    • Crime and security
    • War and peace
    • Development
    • Cities
    • Regions
    • Provinces
  • Profiles
    • Organized crime
    • Politics
    • Armed conflict
    • Economy
    • Sports
  • Lite
  • Opinion
News

Colombia appeals to World Health Organization in fight for cheaper cancer drug

by Thomas Graham May 24, 2016
3.9K

Colombia’s government has appealed to the World Health Organisation (WHO) to help it break pharmaceutical giant Novartis’ monopoly on a life-saving cancer drug, which would allow the country to buy cheaper, generic versions for its citizens.

On Monday at the World Health Assembly in Geneva, Colombia’s Minister of Health Alejandro Gaviria stated that the sustainable development of countries like Colombia was being threatened by the high prices of necessary drugs.

Novartis’ drug Gleevec was what he had in mind.


Are Swiss Novartis’ private interests threatening US peace funds for Colombia?

Gleevec, or Glivec, is an essential drug for those with certain forms of cancer but, at the moment, Novartis charges nearly double a Colombian’s median annual income for a year of treatment, according to the Huffington Post.

If Novartis’ monopoly on the drug were broken, a generic version of the drug could be produced that could cost 30% less, reported The Intercept.

To begin with, Colombia offered Novartis a proposal where they would lower the price of their drug but keep their monopoly.

Novartis rejected Colombia’s proposal and the two are now locked in a stalemate that looks destined for the courtroom.


Colombia gives Novartis a week to lower price of cancer drug

“The process has been accompanied by a big international debate and also, I want to add clearly, by some pressure,” said the Minister of Health, Alejandro Gaviria

According to Gaviria there is some flexibility when it comes to intellectual property, and the WHO has told countries to use this to promote the rational use of drugs.

“In light of our experience it has become clear that although these flexibilities exist in the theory of treaties and multilateral pronouncements, in practice they are very difficult to apply.”

Gaviria appealed to the WHO to help the states that are looking to break monopolies and promote the distribution of much needed medicines.

122 lawyers and health experts across the world recently signed a letter to the Colombian government endorsing their stance against Novartis. It remains to be seen whether the WHO will officially join them.


Experts defend Colombia in battle with Novartis over cheaper cancer drug

Alejandro Gaviriaministry of healthNovartisPublic health

Contribute

Trending

  • Petro ends ceasefire with FARC dissidents in south Colombia

  • Bogota court refuses to drop fraud and bribery charges against Uribe

  • NGO’s urge Colombia to sink investor protection treaties

For patrons

Downloads for patrons

Related articles

  • Petro sacks three ministers ahead of Colombia’s local elections

  • Why Colombia’s moderates are infighting again

  • Colombia’s moderate election candidates in crisis

  • Twitter
  • Email
  • Rss

@2008-2019 - Colombia Reports. All Rights Reserved.
Powered by Digitale Zaken and Parrolabs


Back To Top
Colombia News | Colombia Reports
  • News
    • General
    • Analysis
    • War and peace
    • Elections
    • Economy
    • Culture
    • Sports
    • Science and Tech
  • Travel
    • General
    • Bogota
    • Medellin
    • Cali
    • Cartagena
    • Antioquia
    • Caribbean
    • Pacific
    • Coffee region
    • Amazon
    • Southwest Colombia
    • Northeast Colombia
    • Central Colombia
  • Data
    • Economy
    • Crime and security
    • War and peace
    • Development
    • Cities
    • Regions
    • Provinces
  • Profiles
    • Organized crime
    • Politics
    • Armed conflict
    • Economy
    • Sports
  • Lite
  • Opinion